Here's Why Iovance Biotherapeutics Jumped 51.3% in February

Shares of Iovance Biotherapeutics (NASDAQ: IOVA) jumped over 51% last month, according to data provided by S&P Global Market Intelligence. While investors were dealing with the broader market sell-off over coronavirus fears, Bloomberg reported that the development-stage biopharma was engaged in takeover talks. That was all investors needed to run into the stock. 

In fact, the pharma stock has proven surprisingly resilient throughout the current market correction. Investors have grown increasingly worried about global economic disruption since the end of February, but shares of Iovance Biotherapeutics have gained 57% since the beginning of February -- and that includes a drop of more than 10% on March 9.

Image source: Getty Images.

Continue reading

Source Fool.com